Investment Type: Venture Capital
Mentions in press and media 7
| Date | Title | Description |
| 03.04.2025 | Orthobrain's $7.5 Million Boost: A New Era for Dental Practices | In the bustling world of dental care, innovation is the name of the game. Orthobrain, a Cleveland-based company, has just secured a hefty $7.5 million in funding. This financial windfall is not just a number; it represents a significant lea... |
| 02.04.2025 | orthobrain: $7.5 Million Raised For Helping Dentists Integrate Orthodontics Into Practices | orthobrain, an orthodontic growth system that empowers dentists and dental service organizations to integrate orthodontics into their practices seamlessly, announced it has raised $7.5 million in growth capital. CareCapital, one of the larg... |
| 13.11.2024 | Impress: A New Era in Orthodontics with €110 Million Boost | In the bustling streets of Barcelona, a revolution in orthodontics is underway. Impress, a trailblazer in invisible aligners, has secured over €110 million in funding. This investment, led by heavyweights like Trinity Capital Inc. and CareC... |
| 12.11.2024 | Barcelona-based Impress secures over €110 million to expand orthodontic services across Europe | Impress, a Barcelona-based orthodontic chain specialising in invisible aligners has raised over €110 million in its latest funding round led by key participants including Trinity Capital Inc., CareCapital, LBO France, and TA Ventures. This ... |
| 07.01.2009 | Anacor takes $50M to treat fungal infections | Anacor Pharmaceuticals, a Palo Alto, Calif. firm working on topical treatments for fungal infections in nails, just got a $50 million infusion in a fifth round of funding. This is pretty good news for a company that had to withdraw its IPO ... |
| 24.12.2008 | Drug developer Anacor cancels IPO plans | Biotech firm Anacor Pharmaceuticals has withdrawn its filing to go public after an arduous 16-month wait (unprecedented for health care enterprises, reports VentureWire). The Palo Alto, Calif.-based company says the market is not optimal to... |
| 10.07.2007 | NephroGenex raises $3.3M for kidney disease | Cary, N.C.-based NephroGenex, a biotech developing personalized therapies for kidney disease, raised $3.3 million of an expected $26.8 million first funding round, VentureWire reports (subscription required), citing an SEC filing (no link a... |